Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 445

1.

Similarities and differences between pediatric and adult patients with systemic lupus erythematosus.

Tarr T, Dérfalvi B, Győri N, Szántó A, Siminszky Z, Malik A, Szabó AJ, Szegedi G, Zeher M.

Lupus. 2015 Jul;24(8):796-803. doi: 10.1177/0961203314563817. Epub 2014 Dec 15.

PMID:
25516474
2.

Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study.

Laczik R, Soltesz P, Szodoray P, Szekanecz Z, Kerekes G, Paragh G, Rajnavölgyi E, Abel G, Szegedi G, Bodolay E.

Rheumatology (Oxford). 2014 Nov;53(11):2035-43. doi: 10.1093/rheumatology/keu236. Epub 2014 Jun 10.

PMID:
24917564
3.

Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.

Bodolay E, Prohászka Z, Paragh G, Csipő I, Nagy G, Laczik R, Demeter N, Zöld E, Nakken B, Szegedi G, Szodoray P.

Immunol Res. 2014 Oct;60(1):50-9. doi: 10.1007/s12026-014-8552-x.

PMID:
24838263
4.

Decreased apopto-phagocytic gene expression in the macrophages of systemic lupus erythematosus patients.

Majai G, Kiss E, Tarr T, Zahuczky G, Hartman Z, Szegedi G, Fésüs L.

Lupus. 2014 Feb;23(2):133-45. doi: 10.1177/0961203313511557. Epub 2013 Nov 27.

PMID:
24285095
5.

Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study.

Hunyadi J, András C, Szabó I, Szántó J, Szluha K, Sipka S, Kovács P, Kiss A, Szegedi G, Altorjay I, Sápy P, Antal-Szalmás P, Tóth L, Fazekas G, Rajnavölgyi É.

Pathol Oncol Res. 2014 Apr;20(2):357-65. doi: 10.1007/s12253-013-9704-3. Epub 2013 Oct 28.

PMID:
24163303
6.

Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders.

Szodoray P, Nakken B, Barath S, Csipo I, Nagy G, El-Hage F, Osnes LT, Szegedi G, Bodolay E.

Hum Immunol. 2013 Dec;74(12):1510-8. doi: 10.1016/j.humimm.2013.08.003. Epub 2013 Aug 20.

PMID:
23974054
7.

Clinical course, prognosis, and causes of death in mixed connective tissue disease.

Hajas A, Szodoray P, Nakken B, Gaal J, Zöld E, Laczik R, Demeter N, Nagy G, Szekanecz Z, Zeher M, Szegedi G, Bodolay E.

J Rheumatol. 2013 Jul;40(7):1134-42. doi: 10.3899/jrheum.121272. Epub 2013 May 1.

PMID:
23637328
8.

Derailed B cell homeostasis in patients with mixed connective tissue disease.

Hajas A, Barath S, Szodoray P, Nakken B, Gogolak P, Szekanecz Z, Zold E, Zeher M, Szegedi G, Bodolay E.

Hum Immunol. 2013 Jul;74(7):833-41. doi: 10.1016/j.humimm.2013.04.007. Epub 2013 Apr 19.

PMID:
23608739
9.

Fatal CMV-Infection after Autologous Stem Cell Transplantation in Refractory Systemic Lupus Erythematosus.

Váróczy L, Kiss E, Tarr T, Zeher M, Szegedi G, Illés A.

Case Rep Transplant. 2012;2012:465089. doi: 10.1155/2012/465089. Epub 2012 Mar 29.

10.

[In memory of Professor Gyula Petrányi (1912-2000)].

Szegedi G, Leövey A.

Orv Hetil. 2012 Dec 2;153(48):1921-2. doi: 10.1556/OH.2012.HO2429. Hungarian. No abstract available.

PMID:
23183008
11.

Distinct phenotypes in mixed connective tissue disease: subgroups and survival.

Szodoray P, Hajas A, Kardos L, Dezso B, Soos G, Zold E, Vegh J, Csipo I, Nakken B, Zeher M, Szegedi G, Bodolay E.

Lupus. 2012 Nov;21(13):1412-22. doi: 10.1177/0961203312456751. Epub 2012 Aug 3.

PMID:
22864236
12.

Serum and urinary cytokine levels of SLE patients.

Brugos B, Vincze Z, Sipka S, Szegedi G, Zeher M.

Pharmazie. 2012 May;67(5):411-3.

PMID:
22764573
13.

[Successful completed pregnancies in patients with systemic lupus erythematosus].

Tarr T, Kiss E, Szegedi G, Zeher M.

Orv Hetil. 2012 Mar 25;153(12):454-60. doi: 10.1556/OH.2012.29323. Hungarian.

PMID:
22411218
14.

Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases.

Szodoray P, Varoczy L, Papp G, Barath S, Nakken B, Szegedi G, Zeher M.

Scand J Rheumatol. 2012 Mar;41(2):110-5. doi: 10.3109/03009742.2011.606788. Epub 2011 Sep 21.

PMID:
21936606
15.

Associations of HLA-shared epitope, anti-citrullinated peptide antibodies and lifestyle-related factors in Hungarian patients with rheumatoid arthritis: data from the first Central-Eastern European cohort.

Besenyei T, Gyetvai A, Szabó Z, Fekete A, Kapitány A, Szodoray P, Laki J, Soós L, Sipka S, Szegedi G, Lakos G, Szekanecz Z.

Joint Bone Spine. 2011 Dec;78(6):652-3. doi: 10.1016/j.jbspin.2011.05.018. Epub 2011 Jul 5. No abstract available.

PMID:
21733730
16.

Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.

Kerekes G, Soltész P, Szucs G, Szamosi S, Dér H, Szabó Z, Csáthy L, Váncsa A, Szodoray P, Szegedi G, Szekanecz Z.

Isr Med Assoc J. 2011 Mar;13(3):147-52.

17.

Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.

Soltész P, Kerekes G, Dér H, Szücs G, Szántó S, Kiss E, Bodolay E, Zeher M, Timár O, Szodoray P, Szegedi G, Szekanecz Z.

Autoimmun Rev. 2011 May;10(7):416-25. doi: 10.1016/j.autrev.2011.01.004. Epub 2011 Jan 31. Review.

PMID:
21281743
18.

Assessment of subclinical vascular disease associated with ankylosing spondylitis.

Bodnár N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Némethné ZG, Szegedi G, Shoenfeld Y, Sipka S, Soltész P, Szekanecz Z, Szántó S.

J Rheumatol. 2011 Apr;38(4):723-9. doi: 10.3899/jrheum.100668. Epub 2011 Jan 15.

PMID:
21239756
19.

Vitamin D insufficiency in a large MCTD population.

Hajas A, Sandor J, Csathy L, Csipo I, Barath S, Paragh G, Seres I, Szegedi G, Shoenfeld Y, Bodolay E.

Autoimmun Rev. 2011 Apr;10(6):317-24. doi: 10.1016/j.autrev.2010.11.006. Epub 2010 Dec 13.

PMID:
21156217
20.

The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary.

Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E.

Scand J Rheumatol. 2011 Mar;40(2):122-6. doi: 10.3109/03009742.2010.507220. Epub 2010 Oct 26.

PMID:
20977384
21.

Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease.

Zold E, Szodoray P, Nakken B, Barath S, Kappelmayer J, Csathy L, Hajas A, Sipka S, Gyimesi E, Gaal J, Barta Z, Hallay J, Szegedi G, Bodolay E.

Autoimmun Rev. 2011 Jan;10(3):155-62. doi: 10.1016/j.autrev.2010.09.018. Epub 2010 Sep 22.

PMID:
20868777
22.

Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome.

Veres K, Szodoray P, Szekanecz Z, Lakos G, Kiss E, Laczik R, Sipka S, Bodolay E, Zeher M, Muszbek L, Szegedi G, Soltész P.

Lupus. 2010 Nov;19(13):1520-6. doi: 10.1177/0961203310374336. Epub 2010 Aug 4.

PMID:
20685773
23.

Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease.

Zold E, Szodoray P, Kappelmayer J, Gaal J, Csathy L, Barath S, Gyimesi E, Hajas A, Zeher M, Szegedi G, Bodolay E.

Scand J Rheumatol. 2010 Nov;39(6):490-7. doi: 10.3109/03009741003781951. Epub 2010 Jul 8.

PMID:
20615161
24.

Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.

Brugos B, Kiss E, Dul C, Gubisch W, Szegedi G, Sipka S, Zeher M.

Hum Immunol. 2010 Sep;71(9):874-7. doi: 10.1016/j.humimm.2010.06.004. Epub 2010 Jun 9.

PMID:
20538031
25.

Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.

Soltesz P, Bereczki D, Szodoray P, Magyar MT, Der H, Csipo I, Hajas A, Paragh G, Szegedi G, Bodolay E.

Arthritis Res Ther. 2010;12(3):R78. doi: 10.1186/ar2999. Epub 2010 May 6.

26.

Oxidized LDL induces in vitro lymphocyte activation in antiphospholipid syndrome.

Laczik R, Szodoray P, Veres K, Lakos G, Sipka S, Szegedi G, Soltész P.

Autoimmunity. 2010 Jun;43(4):334-9. doi: 10.3109/08916930903540440.

PMID:
20187701
27.

Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications.

Szodoray P, Varoczy L, Szegedi G, Zeher M.

Scand J Rheumatol. 2010;39(1):1-11. doi: 10.3109/03009740903030324. Review.

PMID:
20132064
28.

New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.

Gyetvai A, Szekanecz Z, Soós L, Szabó Z, Fekete A, Kapitány A, Teodorescu M, Sipka S, Szegedi G, Lakos G.

Rheumatology (Oxford). 2010 Jan;49(1):25-33. doi: 10.1093/rheumatology/kep338. Epub 2009 Nov 17.

PMID:
19920092
29.

Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy.

Tóth B, Wolff AS, Halász Z, Tar A, Szüts P, Ilyés I, Erdos M, Szegedi G, Husebye ES, Zeher M, Maródi L.

Clin Endocrinol (Oxf). 2010 May;72(5):641-7. doi: 10.1111/j.1365-2265.2009.03740.x. Epub 2009 Oct 26.

PMID:
19863576
30.

Anti-nuscleosome antibody, a reliable indicator for lupus nephritis.

Kiss E, Lakos G, Szegedi G, Poor G, Szodoray P.

Autoimmunity. 2009 Aug;42(5):393-8.

PMID:
19811255
31.

Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome.

Kapitany A, Tarr T, Gyetvai A, Szodoray P, Tumpek J, Poor G, Szegedi G, Sipka S, Kiss E.

Ann N Y Acad Sci. 2009 Sep;1173:545-51. doi: 10.1111/j.1749-6632.2009.04642.x.

PMID:
19758197
32.

Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.

Hajas A, Szodoray P, Barath S, Sipka S, Rezes S, Zeher M, Sziklai I, Szegedi G, Bodolay E.

J Rheumatol. 2009 Sep;36(9):1930-6. doi: 10.3899/jrheum.081314. Epub 2009 Aug 14.

PMID:
19684145
33.

Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.

Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.

Autoimmunity. 2009 Sep;42(6):497-506. doi: 10.1080/08916930902882731.

PMID:
19626489
34.

[Undifferentiated connective tissue disease].

Bodolay E, Szegedi G.

Orv Hetil. 2009 May 10;150(19):867-72. doi: 10.1556/OH.2009.28610. Review. Hungarian.

PMID:
19403430
35.

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis.

Kerekes G, Soltész P, Dér H, Veres K, Szabó Z, Végvári A, Szegedi G, Shoenfeld Y, Szekanecz Z.

Clin Rheumatol. 2009 Jun;28(6):705-10. doi: 10.1007/s10067-009-1095-1. Epub 2009 Mar 25.

PMID:
19319624
36.

A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases.

Soltész P, Dér H, Kerekes G, Szodoray P, Szücs G, Dankó K, Shoenfeld Y, Szegedi G, Szekanecz Z.

Clin Rheumatol. 2009 Jun;28(6):655-62. doi: 10.1007/s10067-009-1118-y. Epub 2009 Feb 18.

PMID:
19224126
37.

Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage?

Szamosi S, Csiki Z, Szomják E, Szolnoki E, Szoke G, Szekanecz Z, Szegedi G, Shoenfeld Y, Szucs G.

Clin Rev Allergy Immunol. 2009 Jun;36(2-3):145-9. doi: 10.1007/s12016-008-8105-y.

PMID:
19093229
38.

Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: follow-up of immunopathological and clinical effects.

Szekanecz Z, Aleksza M, Antal-Szalmás P, Soltész P, Veres K, Szántó S, Szabó Z, Végvári A, Szamosi S, Lakos G, Sipka S, Szegedi G, Varga J, Szücs G.

Clin Rheumatol. 2009 Mar;28(3):347-50. doi: 10.1007/s10067-008-1062-2. Epub 2008 Dec 6.

PMID:
19067103
39.

Vitamin D deficiency in undifferentiated connective tissue disease.

Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi G, Bodolay E.

Arthritis Res Ther. 2008;10(5):R123. doi: 10.1186/ar2533. Epub 2008 Oct 18.

40.

Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction.

Soltesz P, Der H, Veres K, Laczik R, Sipka S, Szegedi G, Szodoray P.

Rheumatology (Oxford). 2008 Nov;47(11):1628-34. doi: 10.1093/rheumatology/ken349. Epub 2008 Sep 9.

PMID:
18782854
41.

[High-dose chemotherapy followed by autologous CD34+ stem cell transplantation in the treatment of severe refractory multisystem autoimmune diseases of adults--first experiences in Hungary].

Váróczy L, Illés A, Kiss E, Szekanecz Z, Soltész P, Sipka S, Kiss A, Udvardy M, Szegedi G, Zeher M.

Orv Hetil. 2008 Jul 27;149(30):1405-12. doi: 10.1556/OH.2008.28321. Hungarian.

PMID:
18621599
42.

Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.

Lakos G, Soós L, Fekete A, Szabó Z, Zeher M, Horváth IF, Dankó K, Kapitány A, Gyetvai A, Szegedi G, Szekanecz Z.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):253-60.

PMID:
18565246
43.

Progressive divergent shifts in natural and induced T-regulatory cells signify the transition from undifferentiated to definitive connective tissue disease.

Szodoray P, Nakken B, Barath S, Gaal J, Aleksza M, Zeher M, Sipka S, Szilagyi A, Zold E, Szegedi G, Bodolay E.

Int Immunol. 2008 Aug;20(8):971-9. doi: 10.1093/intimm/dxn056. Epub 2008 Jun 11.

PMID:
18550583
44.

The complex role of vitamin D in autoimmune diseases.

Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, Szegedi G, Brun JG, Gesztelyi R, Zeher M, Bodolay E.

Scand J Immunol. 2008 Sep;68(3):261-9. doi: 10.1111/j.1365-3083.2008.02127.x. Epub 2008 May 29. Review.

45.

Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.

Szodoray P, Gal I, Barath S, Aleksza M, Horvath IF, Gergely P Jr, Szegedi G, Nakken B, Zeher M.

Scand J Rheumatol. 2008 May-Jun;37(3):205-12. doi: 10.1080/03009740801910361.

PMID:
18465456
46.

Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.

Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z.

Isr Med Assoc J. 2008 Jan;10(1):32-6.

47.

Adenosine inhibits the release of arachidonic acid and its metabolites (AAM) in activated human peripheral mononuclear cells.

Sipka S, Kovács I, Szántó S, Szegedi G, Brugós L, Bruckner G, Szentmiklósi AJ.

Inflamm Res. 2007 Nov;56(11):468-72. doi: 10.1007/s00011-007-7102-6.

PMID:
18224288
48.

Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.

Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P.

J Rheumatol. 2008 Mar;35(3):398-406. Epub 2008 Jan 15.

PMID:
18203326
49.

Sarcoidosis in patients with mixed connective tissue disease: clinical, genetic, serological and histological observations.

Szodoray P, Szollosi Z, Gyimesi E, Takacs I, Mekkel G, Vegh J, Szilagyi A, Zeher M, Szegedi G, Bodolay E.

Rheumatol Int. 2008 Jun;28(8):743-7. doi: 10.1007/s00296-008-0519-6. Epub 2008 Jan 15.

PMID:
18196245
50.

Evaluation of paraoxonase activity in patients with mixed connective tissue disease.

Bodolay E, Seres I, Szodoray P, Csípo I, Jakab Z, Vegh J, Szilagyi A, Szegedi G, Paragh G.

J Rheumatol. 2008 Feb;35(2):237-43. Epub 2007 Dec 15.

PMID:
18085736

Supplemental Content

Loading ...
Support Center